Continuing Medical Education Conferences in Spain
Nov 19 - 21, 2019 | Free | Research and Clinical Research
Partnerships in Clinical Trials (PCT) Europe is organized by KNect365 Life Sciences and will be held from Nov 19 - 21, 2019 at Barcelona International Convention Centre, Barcelona, Catalonia, Spain. Additional details will be posted as soon as they are available.
Nov 20 - 21, 2019 | Free | Healthcare Technology
Biocompatibility for Medical Devices is organized by KNect365 Life Sciences and will be held from Nov 20 - 21, 2019 at Centre Convencions Internacional Barcelona (CCIB), Barcelona, Catalonia, Spain. Best Practice Biocompatibility: Expert Guidance for Testing and Evaluations Take control of your biocompatibility strategy: • Discuss the common biocompatibility pitfalls and understand how they can be avoided • Assess the latest alternatives to animal testing • Hear direct Competent Authority and Notified Body feedback • Biocompatibility around the world - asses harmonisation of ISO 10993 in EU, US and China • Gain clarification on the guidance surrounding chemical characterisation and toxicological risk assessment Hear from ISO/TC 194 experts at the heart of ISO 10993: • Christian Pellevoisin, Scientific Director, Episkin Academy, France • James Moore, Senior Scientist, W.L. Gore, USA • Christopher Parker, Associate Department Head In-Vivo Biocompatibility, Toxikon and member, ISO/TC 194/WG 10 Implantation working group Practical industry feedback to take back to your office: • Understanding how to manage TTC: What should manufacturers do with the information? • Hear about the work Abbott is doing on • Thrombogenicity Testing and the High Failure Rate • Cytotoxicity failures? Understand how to deal with them with Philippe Hasgall, Principal Scientist, Zimmer Biomet, Switzerland Additional details will be posted as soon as information is available.
Nov 21 - 22, 2019 | Free | Urology
ESU-ESUT Masterclass on Lasers in urology is organized by European School of Urology (ESU), EAU Section of Uro-Technology (ESUT) and will be held from Nov 21 - 22, 2019 at Modernist enclosure of Sant Pau - Sant Pau Art Nouveau Site, Barcelona, Catalonia, Spain. Why You Should Attend Learn all laser applications in urology in this high-level masterclass, including treatment of benign prostatic obstruction, bladder and upper tract urothelial carcinoma, renal stones and urinary tract strictures. You will examine the use of contemporary laser systems such as the Holmium laser, 532-nm laser, Thulium laser, Diode laser, Neodidium and other lasers. Fine-tune your skills by learning from live and semi-live surgeries which will provide a realistic and complete spectrum of clinical laser applications. Learn from the best as key opinion leaders share the best practices and their valuable insights. Additional details will be posted as soon as they are available.
Nov 22 - 23, 2019 | Hours 9.00 | EUR €495 | General practice
European Workshop on NASH in Clinical Practice is organized by Expert Medical Events and will be held from Nov 22 - 23, 2019 at Crowne Plaza Barcelona - Fira Center, Barcelona, Cataluna, Spain. Who Should Attend: This interactive workshop is specifically designed for the needs of all clinicians that encounter patients with NASH in their clinical practice. Accreditation: The European NASH Workshop is designated for a maximum of 9 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Course Description: Non-alcoholic fatty liver disease (NAFLD) is an emerging liver disease affecting 25 % of the population worldwide. In 10% of patients, NAFLD progresses into NASH, a fibrogenic phenotype that can potentially result in cirrhosis, liver failure and the formation of hepatocellular carcinoma. Although NAFLD is globally the most prevalent chronic liver disease and the second leading indication for liver transplant evaluation in the US, knowledge concerning the molecular mechanisms favouring the development and progression of the disease are not fully understood. Current understanding supports the hypothesis that environmental and genetic factors equally influence disease progression. Considering the far-reaching societal and economic burden caused by NAFLD, it is of utmost importance to identify and subsequently implement guidelines to stage, diagnose and treat the disease efficiently. In particular, there is an unmet need for approved drugs that allow the pharmacological treatment of (pre-)cirrhotic NASH. By using surrogate endpoints, the drug approval process for NASH is accelerated and approved agents are expected to enter the market in the near future. This workshop aims to train clinicians on current and future treatment options. We specifically aim to provide practical guidance to secondary stakeholders, such as endocrinologists, diabetologists, cardiologists and general practitioners, on how to manage NAFLD/NASH. Objectives: This workshop aims to: • Review current and future treatment options and discuss challenges associated with the implementation of certain treatments • Discuss gaps in current diagnosis and management guidelines and provide guidance on how the management of patients suffering from NASH can be improved • Raise awareness for NASH among important stakeholders such as endocrinologists, diabetologists and cardiologists • Accelerate the implementation of new policies by stimulating cross-disciplinary discussions Why Should You Attend: After attending this workshop, you will have practical knowledge on: • Multidisciplinary clinical management of patients with NASH • Epidemiology, risk factors and diagnosis of NASH • Comorbidities in NASH • Future treatment options fron NASH • Current guidelines used for diagnosing and treating NASH Additional details will be posted as soon as they are available.
Nov 22 - 24, 2019 | EUR €425 | Emergency Medicine | Pulmonary Medicine | Vascular Surgery | Internal Medicine
EHA-SWG Scientific Meeting on Systemic Risk of Thrombosis or Bleeding is organized by European Hematology Association (EHA) and will be held from Nov 22 - 24, 2019 at Melia Avenida America, Madrid, Spain. Target audience: Hematologists, cardiologists, neurologists, pediatricians, internists, patient advocates and clinicians/researchers interested in pathogenesis, diagnosis, and treatment of thrombo-hemorrhagic disorders. Description: The EHA-SWG Scientific Meeting on Systemic Risk of Thrombosis or Bleeding is a three-day meeting dedicated to physicians who take care of patients with thrombotic or hemorrhagic risk. This meeting will teach participants how to recognize these patients, update them on treatments available for reducing these risks, and demonstrate how to weigh the benefits and risk of anti-hemorrhagic and anti-thrombotic therapies. Program: The scientific program covers basic science, pathogenesis, diagnosis and treatment of thrombosis and bleeding disorders, including gender-related hemostatic issues and thrombocytopenias. The participants are encouraged to be part of the program both through sessions specifically dedicated to their presentation of clinical cases and results of their research, and by interacting with the invited speakers during sessions and breaks. This meeting will cover the following topics: • Venous thromboembolism • Biological markers to assess the thrombotic risk • Scoring for bleeding risk • Platelet threshold for anticoagulant treatments • Management of bleeding risk in patients with platelet defects • Bleeding risk of anticoagulation • Gender-related hemostatic disorders • Anticoagulant therapy. Learning objectives: After attending this EHA-SWG Scientific Meeting, you should be able to: • identify the etiology and pathogenesis of thrombosis and bleeding tendency in each patient, • use appropriately clinical and laboratory investigations to evaluate the thrombotic and bleeding risk, • manage patients at risk of thrombosis and hemorrhage during everyday life and on the occasion of hemostatic challenges, • define how to stop bleeding once it occurs, and • consider the cost-benefit ratio in the choice of treatment.
5th Paediatric IBD Masterclass is organized by European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and will be held from Nov 28 - 30, 2019 at Malaga, Andalucia, Spain. Course Description: The goals are to review important aspects of diagnosis and treatment of children and adolescents. This ESPGHAN Masterclass is for practicing pediatric gastroenterologists who wish to improve their clinical skills in managing paediatric IBD. Trainees could be accepted based on availability. Preference will be given to ESPGHAN members. The ESPGHAN Paediatric IBD Porto Group is a group of paediatric IBD experts from ESPGHAN whose goals are to generate collaborative international research and to provide a leadership role concerning current diagnosis and management of IBD in children. Additional details will be posted as soon as they are available.
Dec 02 - 03, 2019 | EUR €615 | Pharmacy and Medicine
Scholars International Conference on Pharmaceutics and Drug Delivery Research is organized by Scholars International Limited and will be held from Dec 02 - 03, 2019 at Rafaelhoteles Forum Alcala, Madrid, Spain. Theme: "Current and Emerging Trends in the Field of Pharmaceutics and Drug Delivery Research" Who Can Attend: • Formulation Scientists • Researchers from Pharmaceutical Companies • Biomedical Engineers • Pharmaceutical Associations and Societies • Professors & Associate Professors • Pharmacists • Research Scholars • Directors/Managers/CEO’s • Presidents & Vice-Presidents Conference Description: Pharmaceutics 2019 aims at sharing new ideas and new technologies amongst the professionals, industrialists and students from research areas of Formulation Design and Drug Delivery to share their recent innovations and applications and indulge in interactive discussions and technical sessions at the event. The Conference will also have a space for companies and/or institutions to present their services, products, innovations and research results. Pharmaceutics 2019 involves the tracks like Drug Delivery Technologies, Novel Drug Delivery Systems, Routes of Drug Administration, Pharmaceutical Nanotechnology, Nucleic Acid Based Drug Delivery, Smart Drug Delivery Systems, Nano Pharmaceutics and Advanced Drug Delivery, Bio therapeutics as Novel Technique in Drug Delivery, Drug Delivery and Device Development, Major Challenges in Drug Delivery, Peptide and Protein Drug Delivery, Drug Delivery Equipment and Machinery, Business Opportunities in Drug Delivery, Vaccine Based Drug Delivery Technology, Drug Delivery and Device Development. The two-day meeting is going to be an event to look forward to for its enlightening symposiums & workshops from established experts of the fi eld, exceptional keynote sessions directed by the best in the business. It will also prove to be a brilliant open door for the representatives from Universities and Institutes to cooperate with the world class researchers and an outstanding opportunity for businesses keen at expanding their global market reach. Interested individuals can confirm their participation by registering for the conference along with their colleagues. Scientific Sessions: • Drug Delivery Technologies • Novel Drug Delivery Systems • Pharmaceutical Technology • Routes of Drug Administration • Pharmaceutical Nanotechnology & Nanomedicine • Advanced Research on Controlled Release • Targeted Drug Delivery System • Microcapsules, Liposomes and Vesicles • Pharmaceutical Formulations • Bioavailability and Drug Absorption • Gene Therapy and Tissue Engineering • Manufacturing Processes and Quality Control • Nucleic Acid Based Drug Delivery • Smart Drug Delivery Systems • Microfluidic platform for Nanoparticle Synthesis • Bio-therapeutics as Novel Technique in Drug Delivery • Major Challenges in Drug Delivery • Peptide and Protein Drug Delivery • Drug Delivery Equipment and Machinery • Vaccine Based Drug Delivery Technology • Biologic Drugs Additional details will be posted as soon as they are available.
Dec 02 - 03, 2019 | USD $699 | Pharmacy and Medicine
Scholars International Conference takes pleasure in inviting the scientific community across the globe to attend the Scholars International Conference on Frontiers in Chemistry and Drug Discovery during December 02-03, 2019 at Rafaelhoteles Forum Alcala, Madrid, Spain around the theme "Enlightening the Advancements and Exploring the New Horizons in Chemistry and Drug Discovery" Why to Attend?? Chemistry Frontiers 2019 Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about Chemistry and Drug Discovery and its advances. This is your best opportunity to reach the largest assemblage of participants from chemistry and drug discovery community that is from academia, Business, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries. Who should attend and Who You’ll Meet: • Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of: • Scientist, Research scholars • Pharma/Biotech and Medical Device industries • Hospitals, Associations • Pharmacy institutes • Societies Important Scientific sessions: • General Chemistry • Pharmaceutical Chemistry • Industrial Chemistry • Food Chemistry • Computer Aided Drug Design (CADD) • Physical Chemistry and Chemical Physics • Sustainable, Green, and Environmental Chemistry • Theoretical and Computational Chemistry • Inorganic Chemistry • Materials Chemistry and Many more…. Chemistry Frontiers 2019 is comprised of 25 tracks and 125 sessions designed to offer comprehensive sessions that address current issue. For more scientific sessions and abstract submission, please visit: https://scholarsconferences.com/chemistry-frontiers/scientific-sessions Note: 3 or more members from the same lab/institute/university (or) anyone who wish to attend Chemistry Frontiers 2019 Conferences is eligible to get special benefits
Jan 11 - 12, 2020 | CE 12.00 | USD $480 | Neuroscience
Developmental Neurobiology Course is organized by International Chiropractic Pediatric Association (ICPA) and will be held from Jan 11 - 12, 2020 at Barcelona College of Chiropractic (BCC), Barcelona, Catalonia, Spain. This CME Conference has been approved for a maximum of 12 hours of continuing education credits. Course Description: From infancy throughout childhood, understanding and evaluating the pediatric nervous system is both challenging and rewarding. This module will focus on the important physiological intersections that impact spinal health, quality of life, and the attainment of milestones. Attendees will be exposed to current and contemporary neurological principles addressing the sensory, motor and cognitive systems as well as tone of the autonomic nervous system. Techniques of examination and assessment will be demonstrated throughout the module. Course Goal: This course will provide attendees with a functional and working understanding of the developing nervous system in order to better apply, interpret and organize their clinical procedures and applications to the patients seen in daily practice. Additional details will be posted as soon as they are available.
AOCMF Course - Management of Facial Trauma is organized by AOCMF and will be held from Apr 16 - 17, 2020 at Valladolid, Spain. Additional details will be posted as soon as information is available.